Trials / Completed
CompletedNCT03905161
Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test
Does Rhythmic Auditory Stimulation Influence Walking Speed in the 6-minute Walk Test in Patients With Myasthenia Gravis?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 48 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate if rhythmic auditory stimulation can influence walking speed, during a 6MWT in patients with myasthenia gravis (MG).
Detailed description
Background 1. The 6-minute walk test (6MWT) is widely used in the clinic to measure treatment efficacy and disease progression in patients with neuromuscular diseases and is found valid and reliable to measure decrease in walking speed. 2. Rhythmic auditory stimulation has repeatedly been shown to improve gait parameters in individuals with neurologic impairment. The aim of this study is to investigate if rhythmic auditory stimulation can influence walking speed, during a 6MWT in patients with myasthenia gravis. Patients with MG are asked to complete two 6MWTs separated by minimum 30 minutes of rest. Before the 6MWTs patient is instructed to walk 60 m as fast as possible, and their steps per minute (SPM) is recorded. When completing the 6MWTs, one of the tests is accompanied by music (m6MWT) with a beat per minute (BPM) corresponding to patients' SPM. The order of the 6MWTs is randomly decided by pre-ordered sealed envelopes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 6-minute walk test | The 6-minute walk test (6MWT) is widely used in the clinic to measure treatment efficacy and disease progression in patients with neuromuscular diseases and is found valid and reliable to measure decrease in walking speed for neuromuscular patients. |
Timeline
- Start date
- 2019-02-10
- Primary completion
- 2020-01-10
- Completion
- 2020-01-10
- First posted
- 2019-04-05
- Last updated
- 2020-08-12
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03905161. Inclusion in this directory is not an endorsement.